Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This randomized phase III trial is comparing two different combination chemotherapy regimens
to see how well each works in treating patients with previously untreated rhabdomyosarcoma or
sarcoma. Drugs used in chemotherapy, such as dactinomycin, cyclophosphamide, vincristine, and
topotecan, use different ways to stop tumor cells from dividing so they stop growing or die.
It is not yet known which combination chemotherapy regimen is more effective in treating
rhabdomyosarcoma.